Table 4.
Clinical and laboratory characteristics in patients with RSVB and LVMD, and comparison with those patients with normal LV function.
| Variable | LVMD (n = 9; 18%) | Normal LV Function (n = 41; 82%) | p Value |
|---|---|---|---|
| Age (months) | 2 (1–4.5) | 2 (1–6.5) | 0.538 |
| Female sex | 2 (22) | 18 (44) | 0.230 |
| BSA (m2) | 0.29 (0.18–0.33) | 0.28 (0.18–0.43) | 0.742 |
| Time of symptoms (days) | 2 (1.5) | 3 (1–7) | 0.488 |
| BROSJOD score | 11 (9–14) | 6 (1–13) | <0.001 |
| SpO2 (%) | 90 (87–93) | 94 (88–98) | <0.001 |
| Heart rate (bpm) | 135 (100–164) | 116 (89–179) | 0.141 |
| pH | 7.3 (7.25–7.42) | 7.36 (7.22–7.45) | 0.115 |
| pCO2 (mmHg) | 54 (31–61) | 41 (31–71) | 0.009 |
| Nt-proBNP (pg/mL) | 2221 (891–5532) | 377 (62–1779) | <0.001 |
| PICU admission | 8 (89) | 2 (5) | <0.001 |
LVMD (left ventricular myocardial dysfunction); BSA (Body surface area); PICU (paediatric intensive care unit).